In some cases Biktarvy can cause liver damage which is one of the side effects that some people can experience when taking Biktarvy.
The medicine Biktarvy can cause serious, life-threatening side effects.
These include a buildup of lactic acid in the blood (lactic acidosis) and severe liver problems.
Contact your doctor right away if you have any of the following symptoms that could be signs of lactic acidosis:
Feeling very weak or tired.
The medicine BIKTARVY takes up to 4 weeks to start working once you begin taking it.
Biktarvy Is a treatment for HIV infection, that contains three antiviral medicines emtricitabine, tenofovir alafenamide and bictegravir.
Biktarvy starts reducing the HIV viral load in a little as 4 weeks and continues to decrease the levels over the first 3 to 6 months to usually become undetectable.
BIKTARVY is a prescription medicine used to treat HIV-1 in adults and children who weigh at least 55 pounds.
Biktarvy is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body.
Biktarvy is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS).
However this medicine is not a cure for HIV or AIDS.
Biktarvy is a prescription medicine approved by the U.S.
Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children weighing at least 31 lb (14 kg) and who meet certain requirements, as determined by a health care provider.
BIKTARVY is a complete, 1-pill, once-a-day prescription medicine.
A person can contract HIV-1 when bodily fluids containing the virus come into contact with their blood or mucous membranes.
Common ways this can happen are during sex without a condom and through sharing injection drug equipment. HIV-1 infects immune cells called CD4 cells.
Biktarvy should be taken at least 2 hours before, or with food 2 hours after, antacids containing magnesium and/or aluminium.
Biktarvy should be taken at least 2 hours before iron supplements or taken with food.
Biktarvy Is a treatment for HIV infection, that contains three antiviral medicines emtricitabine, tenofovir alafenamide and bictegravir.
Biktarvy starts reducing the HIV viral load in a little as 4 weeks and continues to decrease the levels over the first 3 to 6 months to usually become undetectable.